| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/20/2000 | WO2000003742A3 Solid oral dosage form comprising a combination of metformin and glibenclamide |
| 04/20/2000 | WO2000001713A9 Diacylglycerol acyl transferase proteins |
| 04/20/2000 | WO1999067407A3 Transgenetic non-human animal which comprises an inactive peg3 gene, and the use thereof |
| 04/20/2000 | DE19845405A1 Arylsubstituierte Propanolaminderivate und deren Verwendung Aryl-substituted Propanolaminderivate and their use |
| 04/20/2000 | CA2653503A1 The use of ara as a supplement for a lactating woman |
| 04/20/2000 | CA2347225A1 Pharmaceutical formulations for use in estrogen deprivation syndrome |
| 04/20/2000 | CA2347092A1 1,2-disubstituted cyclopropanes |
| 04/20/2000 | CA2346943A1 Cyclic tetrapeptide compound and use thereof |
| 04/20/2000 | CA2346775A1 Protein kinase homologs |
| 04/20/2000 | CA2346006A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | CA2344696A1 Prevention of uv-induced functional vitamin a deficiency through use of topically applied retinoid |
| 04/20/2000 | CA2314004A1 Matrix-remodeling genes |
| 04/19/2000 | EP0994185A2 Method for culturing Langerhans islets cells |
| 04/19/2000 | EP0994102A1 Cyclic derivatives with a cycloalkylenic chain, process for their preparation and pharmaceutical compositions containing them |
| 04/19/2000 | EP0994093A1 Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same |
| 04/19/2000 | EP0993449A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
| 04/19/2000 | EP0993439A1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 04/19/2000 | EP0993437A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 04/19/2000 | EP0993433A1 Method for producing calcium pyruvates |
| 04/19/2000 | EP0769950A4 Method and compound for the treatment of hair loss |
| 04/19/2000 | CN1251112A Cross-linked vinyl polymers with bile acid adsorbing effect |
| 04/19/2000 | CN1251099A Thiazole benzenesulfonamides as beta 3 agoniste for treatment of diabetes and obesity |
| 04/19/2000 | CN1251093A Process for producing optically active imidazole compound, intermediates for synthesizing same |
| 04/19/2000 | CN1250771A Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same |
| 04/19/2000 | CN1250618A Food additive benefiting patients of diabetics, coronary heart disease and tumor and its preparing method |
| 04/19/2000 | CN1250617A Process for preparing additive rich in organic iodine compound from plant |
| 04/19/2000 | CN1051459C Health-care medicament for rehabilitating function of human body |
| 04/18/2000 | US6051686 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 04/18/2000 | US6051613 Nitrogen monoxide production suppressor |
| 04/18/2000 | US6051583 2,3,3a,4,9,9a-hexahydro-8-hydroxy-1H-benz[f]indoles, processes for preparing them and their use as pharmaceutical compositions |
| 04/18/2000 | US6051551 Antidiabetic agents; hypoglycemic agents; inhalationadministering |
| 04/18/2000 | US6051234 Health diet for preventing diseases caused by life-habit |
| 04/17/2000 | CA2286530A1 Method for culturing langerhans islets and islet autotransplantation islet regeneration |
| 04/13/2000 | WO2000020645A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF TUMOR NECROSIS FACTOR-α (TNF-α) EXPRESSION |
| 04/13/2000 | WO2000020635A1 ANTISENSE MODULATION OF INTEGRIN α4 EXPRESSION |
| 04/13/2000 | WO2000020621A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | WO2000020458A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 04/13/2000 | WO2000020448A2 Nlk1 -interacting proteins |
| 04/13/2000 | WO2000020437A1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism |
| 04/13/2000 | WO2000020434A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | WO2000020423A1 Tricyclic δ3-piperidines as pharmaceuticals |
| 04/13/2000 | WO2000020421A2 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS |
| 04/13/2000 | WO2000020410A1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof |
| 04/13/2000 | WO2000020397A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | WO2000020393A1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 04/13/2000 | WO2000020392A1 Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use |
| 04/13/2000 | WO2000020376A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 04/13/2000 | WO2000020370A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 04/13/2000 | WO2000020014A1 Plant extracts for the treatment of increased bone resorption |
| 04/13/2000 | WO2000020011A1 Isolated dna encoding human h3 histamine receptor |
| 04/13/2000 | WO2000020007A1 Method and compositions for increasing bone mass |
| 04/13/2000 | WO2000019998A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin |
| 04/13/2000 | WO2000019883A2 Compositions and methods of disease diagnosis and therapy |
| 04/13/2000 | WO2000003015A3 Human transport protein homologs |
| 04/13/2000 | WO2000002850A3 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 04/13/2000 | DE19845406A1 Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Substituted 1,3-diaryl-2-pyridin-2-yl-3- (pyridin-2-ylamino) - propanol derivatives, process for their preparation, pharmaceutical compositions containing them and their use |
| 04/13/2000 | DE19845403A1 Mit Gallensäuren verknüpfte Porpanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung With bile acids linked Porpanolaminderivate, processes for their preparation, pharmaceutical compositions containing them and their use |
| 04/13/2000 | DE19845402A1 Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung -Containing heterocycles substituted with Propanolaminderivate, process for their production, medicaments containing these compounds and their use |
| 04/13/2000 | CA2347120A1 Nlk1 -interacting proteins |
| 04/13/2000 | CA2346765A1 Compositions and methods of disease diagnosis and therapy |
| 04/13/2000 | CA2346456A1 Method and compositions for increasing bone mass |
| 04/13/2000 | CA2346363A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 04/13/2000 | CA2346339A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 04/13/2000 | CA2346333A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin |
| 04/13/2000 | CA2346217A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | CA2346085A1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism |
| 04/13/2000 | CA2346083A1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof |
| 04/13/2000 | CA2346037A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | CA2346034A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 04/13/2000 | CA2345209A1 Antisense modulation of integrin .alpha.4 expression |
| 04/13/2000 | CA2344973A1 Oxidoreductase molecules |
| 04/13/2000 | CA2344616A1 Antisense oligonucleotide modulation of tumor necrosis factor-.alpha. (tnf-.alpha.) expression |
| 04/13/2000 | CA2344266A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/12/2000 | EP0992503A1 Process for producing isooxazolidinedione compound |
| 04/12/2000 | EP0992496A1 Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as CETP inhibitors |
| 04/12/2000 | EP0991654A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 04/12/2000 | EP0991636A1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 04/12/2000 | EP0991632A1 New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives |
| 04/12/2000 | EP0991618A1 Selective thyroid hormone analogs |
| 04/12/2000 | EP0991616A1 METHOD FOR PRODUCING MEDICAMENTS CONTAINING HMG-CoA-REDUCTASE INHIBITORS |
| 04/12/2000 | EP0991424A1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor |
| 04/12/2000 | EP0991420A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands |
| 04/12/2000 | CN1250448A Improved method for producing thiazolidinediones, and new thiazolidinediones |
| 04/12/2000 | CN1250051A New indane-1-alcohol compound, its preparation method and medical composition containing the same |
| 04/12/2000 | CN1051313C 5-arylindole derivatives and its use, pharmaceutical composition containing the same and intermediate for preparing them |
| 04/12/2000 | CN1051312C Thiazolidine derivatives and its pharmaceutical useage |
| 04/12/2000 | CN1051311C N-heteroaryl-n'-phenylurea derivatives, their production and use |
| 04/12/2000 | CN1051298C Substituted cyclohexanolester, its use for treatment of disease and pharmaceutical agent |
| 04/12/2000 | CN1051227C Application in preparation of fluorinated vitamin D3 derivative |
| 04/11/2000 | US6048965 Polypeptide that controls the premature degradation of transcripts |
| 04/11/2000 | US6048891 Administering mixtures with 6-hydroxy-2,7,8-trimethyl-chroman-2-propanoic acid for treatment of cardiovascular and kidney disorders |
| 04/11/2000 | US6048884 Antidiabetic agents; hypoglycemic agents |
| 04/11/2000 | US6048883 Hypoglycemic agent |
| 04/11/2000 | US6048880 Therapy for cytokine sensitive diseases |
| 04/11/2000 | US6048873 Skin disorders |
| 04/11/2000 | US6048872 Dietetics; antidiabetic agents; cardiovascular disorders; gastrointestinal disorders |
| 04/11/2000 | US6048724 Producing mammalian transfected cell strain which expresses exogenous dna encoding erythropoietin and glucagons; for prevention or treatment of a condition in which insulin production or glucagon function is defective |
| 04/11/2000 | US6048524 In vivo production and delivery of erythropoietin for gene therapy |
| 04/11/2000 | US6048523 Polyester cyclic compounds, their complexes and bonded bodies |
| 04/11/2000 | CA2009579C Insulin analogs |